Ultrathin-Wall Heat Shrink Tubing Ideal Solution For Microablation Device

A virtual start-up identified a significant opportunity to develop a catheter-based embolic protection device for high-risk patients undergoing transcatheter aortic valve replacement (TAVR). Lacking technical expertise, the company outsourced all engineering needs to Nordson MEDICAL, a trusted partner for design, development, and manufacturing services.
Nordson’s team worked closely with the start-up’s founders, developing the product concept through extensive feasibility studies and product development phases. They optimized the device's design to be user-friendly and compatible with physician preferences. After initial progress, the project was paused for several months due to clinical evaluations and fundraising, a flexible arrangement supported by Nordson's business model.
Upon resumption, Nordson MEDICAL conducted preclinical validation testing, and after about 2.5 years, the first human use of the device occurred. Clinical trials followed in Germany and Canada, culminating in the device receiving a CE mark nearly three years after the initial brainstorming session. The device is now commercially available in Europe.
Throughout the process, Nordson MEDICAL’s support allowed the start-up to remain virtual, avoiding significant overhead and staffing costs. The collaboration expedited the device’s development, resulting in quicker clinical trials and regulatory approvals. Ultimately, the start-up was acquired by a top-ten medical device manufacturer, providing investors with a more than 5-to-1 return on investment.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Med Device Online? Subscribe today.